Project Grant R01AT013668
- Federal Grant Award Summary The National Center for Complementary and Integrative Health (NCCIH) awarded the University of Virginia a $1.63 million Project Grant on May 15, 2025, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to develop and evaluate an adaptive intervention designed to improve pain outcomes in patients with comorbid chronic low back pain and insomnia. The project, which extends through April 30, 2030, will investigate whether adding...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Rochester a Project Grant valued at $226,500 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective January 1, 2026, through December 31, 2027. This award supports fundamental neuroscience research investigating the molecular mechanisms by which transmembrane AMPA receptor regulatory proteins (TARPs) modulate...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Pennsylvania $203,125 under its Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award, effective March 1, 2026 through February 29, 2028, funds a collaborative research project led by Dr. Gregory Corder, Dr. Franz Weber, and Dr. Raquel Adaia Sandoval Ortega to investigate the neural circuit mechanisms underlying the...
- Federal Project Grant Award Summary The University of Rochester received a $464,315 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective July 1, 2025, through June 30, 2030. This research initiative investigates the role of L-type calcium channel CAV1.2 in Achilles tendinopathy, a degenerative tendon condition associated with pain and...
- Federal Project Grant Award Summary The University of Rochester received a $600,000 Project Grant award dated September 5, 2025, from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) to conduct research on psoriatic arthritis (PSA) endotypes and treatment non-response mechanisms. The award supports a 12-month research initiative concluding August 31, 2026, that leverages a humanized mouse model developed using sera and...
- Federal Grant Award Summary Middlebury College received a $540,427 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded August 18, 2025, with completion targeted for June 30, 2028. The project delivers mathematical and computational modeling research aimed at understanding interindividual variation in pain modulation through spinal cord stimulation (SCS). Specifically, the award funds...
- Federal Grant Award Summary The University of Rochester received a $300K project grant awarded September 1, 2025, by the National Science Foundation's Directorate for Mathematical and Physical Sciences (CFDA 47.049) to develop and validate artificial intelligence velocimetry (AIV) technology for measuring cerebrospinal fluid (CSF) flow dynamics within the brain. The primary deliverable is a novel measurement methodology that addresses a critical scientific gap: current technology cannot...
- Federal Grant Award Summary The University of Rochester received a $156,555 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective May 1, 2026, through April 30, 2031. This award supports a postdoctoral research training program focused on leveraging adolescent neuroplasticity mechanisms to enhance adult frontal dopaminergic circuit function in the context of neurodevelopmental disorders. The research...
- Federal Project Grant Award Summary Michigan State University received a $431,750 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective June 1, 2025, through May 31, 2027. The award supports research to investigate the role of CCL12, a chemokine mediator, in postoperative pain management. The project delivers preclinical research services and...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant of $226,530 to The Regents of the University of California, San Francisco under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) effective August 1, 2025, through July 31, 2030. This K23 Career Development Award supports research investigating precision medicine approaches to chronic neuropathic pain through non-invasive...
The University of Rochester received a $550,030 Project Grant award from the National Center for Complementary and Integrative Health (NCCIH) under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), effective April 9, 2026 through December 31, 2030. The research project investigates brain-immune interactions through circadian regulation of glymphatic and lymphatic fluid movement, with the primary objective of identifying novel therapeutic targets for chronic neuropathic pain management. The study will deliver scientific knowledge addressing the relationship between sleep disruptions and chronic pain by examining how the body's cerebrospinal fluid (CSF) circulation follows circadian timing patterns and influences immune cytokine distribution across neuroimmune tissues. The project will produce research outputs across three specific aims: establishing whether the daily glymphatic/lymphatic CSF exchange deteriorates during chronic pain development; determining whether the molecular clock controls CSF and cytokine distribution; and evaluating food restriction as a non-pharmacological intervention to reinforce circadian timing and attenuate chronic pain. These deliverables will advance understanding of chronic pain pathology and generate evidence supporting non-invasive, circadian-aligned therapeutic approaches. The research will be conducted at the University of Rochester's facility in Rochester, New York, and is expected to contribute to the NCCIH's mission of building evidence-based knowledge on complementary and integrative health approaches focused on whole-person health outcomes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $550.0k | 4/9/26 |